Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 167
Filter
1.
Sci Rep ; 10(1): 13870, 2020 08 17.
Article in English | MEDLINE | ID: mdl-32807803

ABSTRACT

Although many advances have been achieved to treat aggressive tumours, cancer remains a leading cause of death and a public health problem worldwide. Among the main approaches for the discovery of new bioactive agents, the prospect of microbial secondary metabolites represents an effective source for the development of drug leads. In this study, we investigated the actinobacterial diversity associated with an endemic Antarctic species, Deschampsia antarctica, by integrated culture-dependent and culture-independent methods and acknowledged this niche as a reservoir of bioactive strains for the production of antitumour compounds. The 16S rRNA-based analysis showed the predominance of the Actinomycetales order, a well-known group of bioactive metabolite producers belonging to the Actinobacteria phylum. Cultivation techniques were applied, and 72 psychrotolerant Actinobacteria strains belonging to the genera Actinoplanes, Arthrobacter, Kribbella, Mycobacterium, Nocardia, Pilimelia, Pseudarthrobacter, Rhodococcus, Streptacidiphilus, Streptomyces and Tsukamurella were identified. The secondary metabolites were screened, and 17 isolates were identified as promising antitumour compound producers. However, the bio-guided assay showed a pronounced antiproliferative activity for the crude extracts of Streptomyces sp. CMAA 1527 and Streptomyces sp. CMAA 1653. The TGI and LC50 values revealed the potential of these natural products to control the proliferation of breast (MCF-7), glioblastoma (U251), lung/non-small (NCI-H460) and kidney (786-0) human cancer cell lines. Cinerubin B and actinomycin V were the predominant compounds identified in Streptomyces sp. CMAA 1527 and Streptomyces sp. CMAA 1653, respectively. Our results suggest that the rhizosphere of D. antarctica represents a prominent reservoir of bioactive actinobacteria strains and reveals it as an important environment for potential antitumour agents.


Subject(s)
Actinobacteria , Culture Techniques/methods , Drug Discovery , Neoplasms/pathology , Actinobacteria/metabolism , Actinomycetales/metabolism , Antarctic Regions , Anthracyclines/isolation & purification , Anthracyclines/metabolism , Anthracyclines/pharmacology , Antineoplastic Agents/isolation & purification , Antineoplastic Agents/metabolism , Antineoplastic Agents/pharmacology , Biological Factors/biosynthesis , Biological Factors/isolation & purification , Biological Factors/pharmacology , Cell Line, Tumor , Cell Proliferation/drug effects , Dactinomycin/biosynthesis , Dactinomycin/isolation & purification , Dactinomycin/pharmacology , Humans , Streptomyces/metabolism
2.
J Antibiot (Tokyo) ; 73(12): 837-844, 2020 12.
Article in English | MEDLINE | ID: mdl-32641781

ABSTRACT

The members of Streptomyces have been identified as a major source of antimicrobial agents with broad spectrum. This study is mainly focused on bioactivity-guided isolation and characterization of bioactive molecule from strain Streptomyces sp. T1317-0309 and its whole-genome sequence analysis for possible isolation of novel natural products. Strain Streptomyces sp. T1317-0309 showed 100% sequence similarity with strain Streptomyces lannensis TA4-8T consisting 10, 453,255 bp of genome with 5 scaffolds and 69.9 mol% G + C content. The genome analyses revealed a total of 17 putative biosynthetic gene clusters (BGCs) responsible for various secondary metabolites including actinomycin, bacteriocin, ectoine, melanin, terpene, siderophore, betalactone, NRPS, T2PKS, and T3PKS. The BGC and bioactivity-guided purification of ethyl acetate extract of strain T1317-0309 showed the great potency of antimicrobial activities against various gram-positive multi-drug resistant human pathogens including MRSA. The BGC-predicted bioactive secondary metabolite was identified by various NMR analyses and confirmed as actinomycin D. In addition, this study reveals the first genome study of Streptomyces lannensis as a novel source for actinomycin D.


Subject(s)
Dactinomycin/biosynthesis , Genome, Bacterial/genetics , Streptomyces/genetics , Fermentation , Genes, Bacterial/genetics , Microbial Sensitivity Tests , Multigene Family/genetics , Phylogeny , RNA, Ribosomal, 16S/genetics , Secondary Metabolism/genetics , Streptomyces/isolation & purification , Streptomyces/metabolism , Whole Genome Sequencing
3.
Appl Microbiol Biotechnol ; 104(4): 1647-1660, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31853567

ABSTRACT

More than two-third of known antibiotics are produced by actinomycetes of the genus Streptomyces. Unfortunately, the production rate from Streptomyces natural antibiotic is extremely slow and thus cannot satisfy industrial demand. In this study, the production of antibiotics by Streptomyces is enhanced by a "superplasmid" which including global regulatory factors afsR, cyclic adenosine receptor protein (CRP), RNA polymerase beta subunits (rpoB) with point mutation and acetyl coenzyme A carboxylase gene (accA2BE), these elements are controlled by the PermE* promoter and then transfer into Streptomyces coelicolor M145, Streptomyces mutabilis TRM45540, Streptomyces hygroscopicus XM201, and Streptomyces hygroscopicus ATCC29253 by conjugation to generate exconjugants. NMR, HPLC, and LC-MS analyses revealed that the superplasmid led to the overproduction of actinorhodin (101.90%), undecylprodigiosin (181.60%) in S. coelicolor M145:: pLQ003, of rapamycin (110%), hygrocin A (163.4%) in S. hygroscopicus ATCC29253:: pLQ003, and of actinomycin D (11.78%) in S. mutabilis TRM45540:: pLQ003, and also to the downregulation of geldanamycin in S. hygroscopicus XM201, but we found that mutant strains in mutant strains of S. hygroscopicus XM201 with regulatory factors inserted showed several peaks that were not found in wild-type strains. The results of the present work indicated that the regulator net working in Streptomyces was not uniform, the superplasmid we constructed possibly caused this overproduction and downregulation in different Streptomyces.


Subject(s)
Anti-Bacterial Agents/biosynthesis , Genetic Engineering/methods , Plasmids/genetics , Streptomyces/genetics , Acetyl-CoA Carboxylase/genetics , Bacteria/drug effects , Benzoquinones/metabolism , Dactinomycin/biosynthesis , Lactams, Macrocyclic/metabolism , Point Mutation , Promoter Regions, Genetic
4.
J Basic Microbiol ; 59(2): 148-157, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30238507

ABSTRACT

Actinomycin peptide synthetase genes constitute two oppositely oriented transcriptional units, acmADR, and acmBC, separated by a non-coding intergenic region. Gene constructs of the intergenic region together with its adjoining gene acmA or acmB from the actinomycin biosynthetic gene cluster of Streptomyces chrysomallus were transferred into Streptomyces lividans TK64. Each construct expressed the respective synthetase indicating divergent promoters. Primer extension revealed for both directions -10 and -35 boxes similar to σ70 -dependent promoters from Streptomyces and E. coli. No conspicuous regulatory sequences were detected. Accordingly, S. chrysomallus-grown in glucose-containing medium-produced the peptide synthetases AcmA and AcmB/C as well as actinomycin during logarithmic growth phase. Alignments with the corresponding intergenic region of the actinomycin biosynthetic gene cluster in Streptomyces antibioticus identified analogous -10 and -35 boxes of σ70 consensus sequence. However, in S. antibioticus-cultivated in the same conditions-AcmA and AcmB/C were at maximum activity in late log phase and actinomycin formation peaked in stationary phase. The different patterns of formation of actinomycin and its peptide synthetases encoded by the highly homologous actinomycin biosynthetic gene clusters in S. chrysomallus and S. antibioticus suggest strain-specific control of biosynthesis in agreement with absence of pathway-specific regulatory genes.


Subject(s)
Dactinomycin/biosynthesis , Peptide Synthases/biosynthesis , Streptomyces antibioticus/metabolism , Streptomyces/metabolism , Bacterial Proteins/genetics , Base Sequence , Cloning, Molecular , Culture Media/chemistry , Dactinomycin/chemistry , Escherichia coli/genetics , Genes, Bacterial/genetics , Genetic Vectors , Glucose/metabolism , Metabolic Networks and Pathways/genetics , Multigene Family , Peptide Synthases/genetics , Promoter Regions, Genetic , Streptomyces/genetics , Streptomyces/growth & development , Streptomyces antibioticus/genetics , Streptomyces antibioticus/growth & development , Transcription, Genetic
5.
J Basic Microbiol ; 55(2): 221-8, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25284744

ABSTRACT

An actinomycete strain named IA1, which produced an antimicrobial compound, was isolated from a Saharan soil in In Amenas, Algeria. The study of the 16S rDNA sequence of this strain permitted to relate it to Streptomyces mutabilis NBRC 12800(T) (99.93% of similarity). Strain IA1 exhibited strong activity against a wide range of plant pathogenic fungi. One bioactive compound produced in large amounts (46.7 mg L(-1) day(-1) ), named YA, was isolated and purified by TLC and reverse phase HPLC. The structure elucidation of the pure substance, using combined data from UV visible, NMR spectra, and mass spectrometry, permitted to identify it as actinomycin D, and was thus found for the first time in S. mutabilis related species. The biocontrol abilities of the strain IA1 and compound YA were evaluated through two diseases, i.e., chocolate spot of field bean and Fusarium wilt of flax. The occurrence of the two fungal diseases was effectively reduced. The reduction of chocolate spot disease symptoms reached 80 and 91.7% with IA1 and YA seedlings pretreatments, respectively. Soil pretreatment with IA1 or YA also allowed to reduce Fusarium wilt disease impact by almost 60%.


Subject(s)
Antifungal Agents/isolation & purification , Antifungal Agents/pharmacology , Dactinomycin/biosynthesis , Dactinomycin/pharmacology , Fusarium/drug effects , Plant Diseases/microbiology , Streptomyces/metabolism , Algeria , Antibiosis , Biological Control Agents , Chromatography, Reverse-Phase , Chromatography, Thin Layer , Dactinomycin/chemistry , Dactinomycin/isolation & purification , Flax/microbiology , Fusarium/physiology , Mass Spectrometry , Microbial Sensitivity Tests , Nuclear Magnetic Resonance, Biomolecular , Seedlings/growth & development , Seedlings/physiology , Sequence Analysis, DNA , Soil Microbiology , Streptomyces/classification , Streptomyces/genetics , Streptomyces/isolation & purification , Vicia faba/microbiology
6.
FEMS Microbiol Lett ; 352(1): 62-8, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24383524

ABSTRACT

Phenazinomycin is a hybrid natural product consisting of two chemical entities, a phenazine and a cyclic terpenoid. Phenazinomycin exhibits potent activity against murine tumors and adriamycin-resistant P388 leukemia cells. Streptomyces iakyrus DSM 41873 is known to produce five actinomycin G2 -G6 . In the previous study, we identified the gene cluster directing the biosynthesis of actinomycin G2 -G4 . Inactivation of acmG5' gene in the actinomycin G gene cluster in S. iakyrus completely abolished the production of actinomycin G. Metabolic profiling, chemical isolation, and structural elucidation of the resulting mutant SIAΔacmG5' showed a previously unnoticed metabolite phenazinomycin in S. iakyrus. In silico analysis identified a hybrid biosynthetic gene cluster in the genome of S. iakyrus that could be responsible for the biosynthesis of phenazinomycin. It is proposed that the perturbation of actinomycin G to enhance the phenazinomycin production in the mutant may result from the lifted competition of chorismate, the common precursor of the biosynthetic pathways of these two structurally unrelated natural products.


Subject(s)
Anti-Bacterial Agents/biosynthesis , Bacterial Proteins/metabolism , Dactinomycin/biosynthesis , Methyltransferases/metabolism , Streptomyces/enzymology , Bacterial Proteins/genetics , Biosynthetic Pathways , Gene Expression Regulation, Bacterial , Gene Silencing , Methyltransferases/genetics , Molecular Sequence Data , Multigene Family , Phenazines/metabolism , Streptomyces/genetics , Streptomyces/metabolism
7.
Appl Environ Microbiol ; 79(20): 6447-51, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23956389

ABSTRACT

Using insertional mutagenesis, we have disrupted the RNase III gene, rnc, of the actinomycin-producing streptomycete, Streptomyces antibioticus. Disruption was verified by Southern blotting. The resulting strain grows more vigorously than its parent on actinomycin production medium but produces significantly lower levels of actinomycin. Complementation of the rnc disruption with the wild-type rnc gene from S. antibioticus restored actinomycin production to nearly wild-type levels. Western blotting experiments demonstrated that the disruptant did not produce full-length or truncated forms of RNase III. Thus, as is the case in Streptomyces coelicolor, RNase III is required for antibiotic production in S. antibioticus. No differences in the chemical half-lives of bulk mRNA were observed in a comparison of the S. antibioticus rnc mutant and its parental strain.


Subject(s)
Dactinomycin/biosynthesis , Ribonuclease III/metabolism , Streptomyces antibioticus/enzymology , Streptomyces antibioticus/metabolism , Blotting, Southern , Blotting, Western , Culture Media/chemistry , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , Gene Knockout Techniques , Genetic Complementation Test , Molecular Sequence Data , Mutagenesis, Insertional , Ribonuclease III/genetics , Sequence Analysis, DNA , Streptomyces antibioticus/genetics , Streptomyces antibioticus/growth & development
8.
Mol Biosyst ; 9(6): 1286-9, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23567908

ABSTRACT

The gene cluster directing actinomycin G biosynthesis in Streptomyces iakyrus has been identified and sequenced. It contains one actinomycin synthetase I (ACMS I) gene and two copies of ACMS II and III genes. Genetic analysis demonstrates a unique partnership between the putative hydroxylation and chlorination activities as both acmG8 and acmG9 genes need to be transcribed for the biosynthesis of actinomycin G2-3, respectively.


Subject(s)
Anti-Bacterial Agents/biosynthesis , Dactinomycin/biosynthesis , Genes, Bacterial , Multienzyme Complexes/genetics , Nucleotidyltransferases/genetics , Peptide Synthases/genetics , Streptomyces/genetics , Base Sequence , DNA, Bacterial/genetics , Halogenation , Hydroxylation , Molecular Sequence Data , Multigene Family , Streptomyces/metabolism
9.
J Antibiot (Tokyo) ; 66(4): 211-8, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23423168

ABSTRACT

Streptomyces chrysomallus and Streptomyces parvulus produce novel C-demethylactinomycins besides their normal actinomycins when fed with 3-hydroxyanthranilic acid (3-HA). The 3-HA is incorporated into pentapeptide lactone precursors in competition with the regular precursor 4-methyl-3-hydroxyanthranilic acid (4-MHA). The resultant 3-HA pentapeptide lactones can condense with each other, as well as with the continuously formed 4-MHA pentapeptide lactones giving C-demethylactinomycins lacking one or both methyl groups in their phenoxazinone chromophores. In case of C-demethylactinomyins lacking one methyl group, the condensation was shown to be regiospecific directing the 3-HA portion almost exclusively to the α-side of the phenoxazinone chromophore. As 3-HA is a weaker substrate for the 4-MHA-incorporating enzyme actinomycin synthetase I than 4-MHA, C-demethylactinomycins never exceeded 7-8% of total actinomycin formed. Surprisingly, C-demethylactinomycins (up to 0.8%) were also found in the actinomycin mixtures of unsupplemented streptomycete cultures after longer cultivation times, indicating the natural presence of 3-HA. Feeding with 3-hydroxykynurenine (3-HK) induced also formation of C-demethylactinomycins indicating that 3-HK is source of 3-HA. Analysis of tryptophan metabolites in the intracellular pools of the streptomycetes using 5-(3)H-tryptophan as radiotracer revealed formation of 4-MHA, but not of 3-HA. This indicates that intracellular 3-HK is almost exclusively converted to 3-hydroxy-4-methylkynurenine (4-MHK), which has been identified previously as direct precursor of 4-MHA. However, small amount of 3-HK leaking out from the 4-MHA pathway can be prematurely converted to 3-HA all along the cultivation of the streptomycetes resulting in the formation of natural C-demethylactinomycins.


Subject(s)
Dactinomycin/biosynthesis , Streptomyces/metabolism , 3-Hydroxyanthranilic Acid/metabolism , Chromatography, High Pressure Liquid , Chromatography, Thin Layer , Dactinomycin/isolation & purification , Mycelium/metabolism , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
10.
Southeast Asian J Trop Med Public Health ; 41(5): 1177-87, 2010 Sep.
Article in English | MEDLINE | ID: mdl-21073039

ABSTRACT

One hundred seventy-seven actinomycetes strains were isolated from soils collected from fruit orchards in Thailand. All were tested for antibacterial activity against seven pathogenic bacteria using co-cultivation methods. Forty strains (22.6%) were active against at least one indicator bacteria. Twenty-seven strains (15.3%) inhibited only gram-positive bacteria, four strains (2.3%) inhibited only gram-negative bacteria, and nine strains (5.1%) showed activity against both. Strain SJE177 had potent activity against all tested bacteria, and was selected for further investigation. A crude ethyl acetate extract of this strain retained inhibitory activity as tested by disk-diffusion method. Analysis of morphological and biochemical characteristics and the 16S rRNA gene sequence indicated this strain belonged to the genus Streptomyces. The strain formed a monophyletic line in a phylogenetic tree of 16S rRNA gene sequences with other Streptomyces reference strains. High performance liquid chromatography (HPLC) analysis showed SJE177 produced actinomycin. Since many isolates showed inhibitory activity against indicator bacteria, these results suggest Thai soil could be an interesting source to explore for antibacterial substances.


Subject(s)
Bacteria/drug effects , Dactinomycin/biosynthesis , Soil Microbiology , Streptomyces/metabolism , Chromatography, High Pressure Liquid , Coculture Techniques , Microbial Sensitivity Tests , Phylogeny , Solvents , Streptomyces/classification , Streptomyces/isolation & purification , Thailand
11.
Biochemistry ; 49(45): 9698-705, 2010 Nov 16.
Article in English | MEDLINE | ID: mdl-20945860

ABSTRACT

The actinomycin biosynthetic gene cluster of Streptomyces chrysomallus harbors two paralogous genes, acmI and acmL, encoding methyltransferases. To unveil their suspected role in the formation of 3-hydroxy-4-methyl-anthranilic acid (4-MHA), the building block of the actinomycin chromophore, each gene was expressed in Escherichia coli. Testing the resulting ∼40 kDa His(6)-tagged proteins with compounds of biogenetic relevance as substrates and S-adenosyl-l-methionine revealed that each exclusively methylated 3-hydroxykynurenine (3-HK) with formation of 3-hydroxy-4-methylkynurenine (4-MHK) identified by its in vitro conversion to 4-MHA with hydroxykynureninase. AcmI and AcmL methylate also hydroxyphenyl-amino propanoic acids such as p-tyrosine, m-tyrosine, or 3,4-dihydroxy-l-phenylalanine (DOPA) but at a lower rate than 3-HK. The presence of the α-amino group was necessary for substrate recognition. Phenolic acids with shorter chains such as 4-hydoxyphenyl-l-glycine (HPG), 3-hydroxybenzoic acid (3-HB), or 3-hydroxyanthranilic acid (3-HA) gave no product. Both enzymes were stereospecific for the optical configuration at α-C with unprecedented antipodal selectivity for the d-enantiomer of 3-HK and the l-enantiomer of p-tyrosine or m-tyrosine. AcmI and AcmL show sequence similarity to various C- and O-methyltransferases from bacteria. Phylogenetic analysis places them into the clade of C-methyltransferases comprising among others orthologues involved in 4-MHA formation of other biosynthesis systems and methyltransferases putatively involved in the C-methylation of tyrosine. Remarkably, computational remodelling of AcmI and AcmL structures revealed significant similarity with the 3-D structures of type 1 O-methyltransferases from plants such as caffeic acid O-methyltransferase (COMT) and other phenylpropanoid methyltransferases. The relevance of 3-HK or 3-HA methylation in the actinomycin biosynthesis pathways of different actinomycetes is discussed.


Subject(s)
Amino Acids/metabolism , Dactinomycin/biosynthesis , Methyltransferases/metabolism , Amino Acid Sequence , Base Sequence , Chromatography, Thin Layer , DNA Primers , DNA, Bacterial/genetics , Dactinomycin/chemistry , Escherichia coli/enzymology , Kynurenine/metabolism , Methylation , Methyltransferases/genetics , Methyltransferases/isolation & purification , Models, Molecular , Phenols/metabolism , Plasmids/chemistry , Plasmids/genetics , Restriction Mapping , Streptomyces/enzymology , Streptomyces/genetics , Substrate Specificity , Tyrosine/metabolism
12.
J Bacteriol ; 192(10): 2583-95, 2010 May.
Article in English | MEDLINE | ID: mdl-20304989

ABSTRACT

A gene cluster was identified which contains genes involved in the biosynthesis of actinomycin encompassing 50 kb of contiguous DNA on the chromosome of Streptomyces chrysomallus. It contains 28 genes with biosynthetic functions and is bordered on both sides by IS elements. Unprecedentedly, the cluster consists of two large inverted repeats of 11 and 13 genes, respectively, with four nonribosomal peptide synthetase genes in the middle. Nine genes in each repeat have counterparts in the other, in the same arrangement but in the opposite orientation, suggesting an inverse duplication of one of the arms during the evolution of the gene cluster. All of the genes appear to be organized into operons, each corresponding to a functional section of actinomycin biosynthesis, such as peptide assembly, regulation, resistance, and biosynthesis of the precursor of the actinomycin chromophore 4-methyl-3-hydroxyanthranilic acid (4-MHA). For 4-MHA synthesis, functional analysis revealed genes that encode pathway-specific isoforms of tryptophan dioxygenase, kynurenine formamidase, and hydroxykynureninase, which are distinct from the corresponding enzyme activities of cellular tryptophan catabolism in their regulation and in part in their substrate specificity. Phylogenetic analysis indicates that the pathway-specific tryptophan metabolism in Streptomyces most probably evolved divergently from the normal pathway of tryptophan catabolism to provide an extra or independent supply of building blocks for the synthesis of tryptophan-derived secondary metabolites.


Subject(s)
Bacterial Proteins/genetics , Dactinomycin/biosynthesis , Dactinomycin/chemistry , Multigene Family/genetics , Protein Isoforms/genetics , Streptomyces/metabolism , Arylformamidase/genetics , Arylformamidase/metabolism , Bacterial Proteins/metabolism , Chromatography, Thin Layer , Dactinomycin/metabolism , Hydrolases/genetics , Hydrolases/metabolism , Molecular Sequence Data , Molecular Structure , Mutation , Protein Isoforms/metabolism , Sequence Analysis, DNA , Stereoisomerism , Streptomyces/genetics , ortho-Aminobenzoates/metabolism
13.
Org Biomol Chem ; 7(3): 444-50, 2009 Feb 07.
Article in English | MEDLINE | ID: mdl-19156308

ABSTRACT

Streptomyces sp. strain Gö-GS12 was found to produce five novel actinomycins Y(1)-Y(5) (). Their amino acid pattern discloses them as members of a new family of this important class of antibiotics. Compounds differ from Z-type actinomycins in their beta-peptidolactone rings which here contain trans-4-hydroxyproline (Hyp) or 4-oxoproline (OPro) amino acids, and from the X-congeners by containing methylalanine (MeAla). Within the new Y-type actinomycins variations are not only in the rare chlorinated or hydroxylated threonine residue. Furthermore, the beta-ring can undergo rearrangement by a two-fold acyl shift (compounds and ) or show a unique additional ring closure with the chromophore (compound ), resulting in metabolites with yet unknown structural motifs, altered conformations and distinct bioactivities. The strongest bioactivity was found for the chlorine containing actinomycin Y(1) (), the most surprising for Y(5) () with cytotoxic and antibacterial effects losing their coherence, which has been observed for the first time here.


Subject(s)
Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Cytotoxins/chemistry , Cytotoxins/pharmacology , Dactinomycin/chemistry , Dactinomycin/pharmacology , Streptomyces/metabolism , Amino Acids/chemistry , Anti-Bacterial Agents/biosynthesis , Anti-Bacterial Agents/isolation & purification , Antineoplastic Agents/chemistry , Antineoplastic Agents/isolation & purification , Antineoplastic Agents/metabolism , Antineoplastic Agents/pharmacology , Bacteria/drug effects , Cell Line, Tumor , Cytotoxins/isolation & purification , Cytotoxins/metabolism , Dactinomycin/biosynthesis , Dactinomycin/isolation & purification , Humans , Magnetic Resonance Spectroscopy , Stereoisomerism , Structure-Activity Relationship
14.
Curr Top Med Chem ; 8(8): 710-24, 2008.
Article in English | MEDLINE | ID: mdl-18473893

ABSTRACT

Bioactive natural products are frequently glycosylated with saccharide chains of variable length. These sugars are important for the biological activity of the compounds and they contribute to the interaction with the biological target. The increasing knowledge of sugar biosynthesis pathways and the isolation of a large number of sugar gene clusters from antibiotic-producing actinomycetes are providing tools for combinatorial biosynthesis approaches that can generate potentially improved derivatives with altered sugars in their architecture. Novel derivatives of known bioactive natural products can be produced either in the producer organisms or in heterologous hosts by using different combinatorial biosynthesis strategies. In this article, recent advances in the field are discussed, illustrating the alternative approaches of gene inactivation, gene expression, combining gene inactivation and gene expression, co-expression of genes from different pathways or the use of sugar cassette plasmids to endow a host with the capability of synthesizing new sugars.


Subject(s)
Biological Products/biosynthesis , Biological Products/chemistry , Deoxy Sugars/biosynthesis , Deoxy Sugars/chemistry , Dactinomycin/biosynthesis , Dactinomycin/chemistry , Multigene Family/genetics , Plasmids/genetics , Staurosporine/biosynthesis , Staurosporine/chemistry
15.
J Ind Microbiol Biotechnol ; 35(7): 729-34, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18347826

ABSTRACT

The effects of cultivation medium compositions including soybean meal, peptone, soybean oil and cornstarch for actinomycin X2 production by Streptomyces spp JAU4234 were accessed by using response surface methodology. The 2(4) full factorial designs and the paths of steepest ascent were effective in searching for the major factors of actinomycin X2 production. In this study, cornstarch and soybean oil showed negative effect on actinomycin X2 production based on the first-order regression coefficients derived from MINITAB software. Subsequently, a central composite design for optimization was further investigated. Preliminary studies showed that soybean meal and peptone were believed to be the major factors for actinomycin X2 production. Estimated optimum compositions for the production of actionmycin X2 were as follows (g/l): soybean meal 21.65 and peptone 9.41, and result in a maximum actionmycin X2 production of 617.4 mg/l. This value was closed to the 612 mg/l actionmycin X2 production from actual experimental observations. The yield of actionmycin X2 was increased by 36.9% by culturing the strain Streptomyces spp JAU4234 in the nutritionally optimized fermentation medium.


Subject(s)
Culture Media/chemistry , Dactinomycin/analogs & derivatives , Streptomyces/growth & development , Streptomyces/metabolism , Dactinomycin/biosynthesis , Peptones/metabolism , Soybean Oil/metabolism , Glycine max/metabolism , Starch/metabolism , Statistics as Topic
16.
Indian J Exp Biol ; 46(2): 138-44, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18335813

ABSTRACT

Production of actinomycin-D, by an isolate, S. sindenensis, was optimized by statistical methods. Fructose peptone and NaNO3 were found to be critical for antibiotic production. In the second step, their concentrations were optimized with Central Composite Design and Response Surface Methodology. Fructose, peptone and NaNO3 at 2.55, 0.309 and 0.114% respectively gave approximately 261% higher yield (289 mg/l). Cultivation in fermentor at 600 rpm agitation and 1.5 vvm aeration with optimized medium gave 3.56 folds higher yield (365 mg/l) as compared to the yields in shake flasks using normal production medium (80 mg/l).


Subject(s)
Dactinomycin/biosynthesis , Models, Statistical , Streptomyces/metabolism , Biomass , Bioreactors , Drug Industry , Molecular Sequence Data , RNA, Ribosomal, 16S , Streptomyces/classification , Streptomyces/genetics
17.
Appl Microbiol Biotechnol ; 70(4): 403-11, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16091928

ABSTRACT

Previous studies examining metabolic characteristics of bacterial cultures have mostly suggested that reduced gravity is advantageous for microbial growth. As a consequence, the question of whether space flight would similarly enhance secondary metabolite production was raised. Results from three prior space shuttle experiments indicated that antibiotic production was stimulated in space for two different microbial systems, albeit under suboptimal growth conditions. The goal of this latest experiment was to determine whether the enhanced productivity would also occur with better growth conditions and over longer durations of weightlessness. Microbial antibiotic production was examined onboard the International Space Station during the 72-day 8A increment. Findings of increased productivity of actinomycin D by Streptomyces plicatus in space corroborated with previous findings for the early sample points (days 8 and 12); however, the flight production levels were lower than the matched ground control samples for the remainder of the mission. The overall goal of this research program is to elucidate the specific mechanisms responsible for the initial stimulation of productivity in space and translate this knowledge into methods for improving efficiency of commercial production facilities on Earth.


Subject(s)
Anti-Bacterial Agents/biosynthesis , Dactinomycin/biosynthesis , Space Flight , Streptomyces/metabolism , Spores, Bacterial/physiology , Spores, Bacterial/ultrastructure , Streptomyces/ultrastructure
18.
Appl Microbiol Biotechnol ; 72(1): 145-154, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16374634

ABSTRACT

A new actinomycete strain designated MITKK-103 was isolated from the soil of a flowerpot using a humic acid agar medium. The newly isolated strain was able to produce a large amount of actinomycin X2 even under nonoptimized growing conditions and serves as a promising source of this antibiotic. Actinomycin X2 has higher cytotoxicity toward cultured human leukemia (HL-60) cells than does actinomycin D, and it induces cell death via apoptosis. A nearly complete 16S ribosomal DNA (rDNA) sequence from the isolate was determined and found to have high identity (98.5-100%) with Streptomyces galbus, Streptomyces griseofuscus, and Streptomyces padanus, indicating that MITKK-103 belongs to the genus Streptomyces. The isolate clustered with species belonging to the S. padanus clade in a 16S-rDNA-based phylogenetic tree and showed 75% overall homology to S. padanus ATCC 25646 in DNA-DNA relatedness analysis. Although the growth of the isolate was somewhat different from the three species mentioned, the strain MITKK-103 most closely resembles S. padanus on the basis of the morphological and phenotypic characteristics, phylogenetic analysis, and genotypic data. As such, this is the first report of a strain of S. padanus capable of producing actinomycins.


Subject(s)
Dactinomycin/analogs & derivatives , Soil Microbiology , Streptomyces/metabolism , Bacterial Typing Techniques , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , DNA, Ribosomal/chemistry , DNA, Ribosomal/genetics , Dactinomycin/biosynthesis , Dactinomycin/toxicity , HL-60 Cells , Humans , Microscopy, Electron, Scanning , Molecular Sequence Data , Nucleic Acid Hybridization , Phylogeny , Pigments, Biological/biosynthesis , RNA, Ribosomal, 16S/genetics , Sequence Analysis, DNA , Sequence Homology, Nucleic Acid , Streptomyces/classification , Streptomyces/isolation & purification , Streptomyces/ultrastructure
19.
Bioorg Chem ; 33(3): 136-48, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15888307

ABSTRACT

Electron-rich aromatic compounds undergo a facile tandem reaction sequence involving an iterative two-electron oxidation/aromatization. This review will describe the application of this motif to the synthesis of dimethylbenzimidazole, pyoverdine, actinomycin, cystodytin, pyrroloquinoline quinone, and the cataract pigment.


Subject(s)
Electrons , Hydrocarbons, Aromatic/metabolism , Benzimidazoles/chemistry , Benzimidazoles/metabolism , Catalysis , Dactinomycin/biosynthesis , Dactinomycin/chemistry , Enzymes/chemistry , Enzymes/metabolism , Hydrocarbons, Aromatic/chemistry , Ligands , Molecular Conformation , Oligopeptides/biosynthesis , Oligopeptides/chemistry , Oxidation-Reduction , Pigments, Biological/biosynthesis , Pigments, Biological/chemistry , Quinones/chemistry , Quinones/metabolism
20.
Dalton Trans ; (7): 1056-60, 2004 Apr 07.
Article in English | MEDLINE | ID: mdl-15252684

ABSTRACT

[Fe(Hdmg)(2)(MeIm)(2)](1), referred to as ferroxime(II), is the precursor of a selective catalyst for the oxidative dehydrogenation of 2-aminophenol (Hap) to 2-amino-3H-phenoxazine-3-one (apx) by dioxygen under ambient conditions. The superoxoferroxime(III) species has been detected by ES-MS, and a 4-substituted 2-aminophenoxyl free radical by the ESR technique. The kinetics of the reaction was followed spectrophotometrically and by monitoring dioxygen uptake at constant pressure. According to the proposed mechanism, solvolysis of 1 is followed by O(2) binding to afford a superoxoferroxime, which abstracts an H-atom from Hap in the rate-determining step via an H-bonded intermediate, generating the free radical. This is supported by the observed primary deuterium kinetic isotope effect of 2.63. The system studied is a functional phenoxazinone synthase model.


Subject(s)
Aminophenols/chemistry , Biomimetic Materials/chemistry , Ferrous Compounds/chemistry , Models, Biological , Oxidoreductases/chemistry , Oxidoreductases/metabolism , Oxygen/chemistry , Catalysis , Dactinomycin/biosynthesis , Electron Spin Resonance Spectroscopy , Isotopes , Kinetics , Molecular Structure , Oxidation-Reduction , Spectrometry, Mass, Electrospray Ionization
SELECTION OF CITATIONS
SEARCH DETAIL
...